Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change

Kidney International

Volumn 68, Issue 1, 2005, Pages 121-132

  Kuusniemi, Arvi Matti ^a   Lapatto, Risto ^a   Holmberg, Christer ^a   Karikoski, Riitta ^a   Rapola, Juhani ^a   Jalanko, Hannu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

NAP 2; Nephrin; Oxidative stress; Proteinuria; Tubulointerstitial fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD14 ANTIGEN; CHEMOKINE; COLLAGEN; CYTOKINE ANTIBODY; GELATINASE A; GELATINASE B; GLUTATHIONE; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL ACTIVATING PROTEIN 2; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; VIMENTIN; CYTOKINE; MEMBRANE PROTEIN; NEPHRIN;

ARTERY INTIMA PROLIFERATION; ARTICLE; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INFLAMMATORY CELL; INTERSTITIUM; KIDNEY FIBROSIS; KIDNEY TUBULE; MICROVASCULATURE; MYOFIBROBLAST; NEPHRECTOMY; NEPHRITIS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; WESTERN BLOTTING; CAPILLARY; FIBROSIS; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MONOCYTE; NEPHROTIC SYNDROME; PATHOLOGY;

CAPILLARIES; CHEMOKINES; CHILD, PRESCHOOL; CYTOKINES; FIBROSIS; HUMANS; INFANT; KIDNEY TUBULES; MACROPHAGES; MEMBRANE PROTEINS; MONOCYTES; NEPHRITIS; NEPHROTIC SYNDROME; OXIDATIVE STRESS; PHENOTYPE; PROTEINURIA;

EID: 24944554995     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00386.x     Document Type: Article

References (43)

1. RUGGENENTI P, REMUZZI G: The role of protein traffic in the progression of renal diseases. Annu Rev Med 51:315-327, 2000
2. ZOJA C, BENIGNI A, REMUZZI G: Cellular responses to protein overload: Key event in renal disease progression. Curr Opin Nephrol Hypertens 13:31-37, 2004
3. ANDERS HJ, VIELHAUER V, SCHLONDORFF D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63:401-415, 2003
4. BOTTINGER EP, BITZER M: TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600-2610, 2002
5. LIU Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1-12, 2004
6. KESTILA M, LENKKERI U, MANNIKKO M, et al: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
7. PATRAKKA J, KESTILA M, WARTIOVAARA J, et al: Congenital nephrotic syndrome (NPHS1): Features resulting from different mutations in Finnish patients. Kidney Int 58:972-980, 2000
8. FURNESS PN: The use of digital images in pathology. J Pathol 183:253-263, 1997
9. LIN Y, HUANG R, CHEN LP, et al: Profiling of cytokine expression by biotin-labeled-based protein arrays. Proteomics 3:1750-1757, 2003
10. TILLY JL: Use of the terminal transferase DNA labeling reaction for the biochemical and in situ analysis of apoptosis, in Cell Biology: A Laboratory Handbook (vol. 1). edited by Celis JE, San Diego, Academic Press, 1994, pp 330-337
11. AHOLA T, FELLMAN V, LAAKSONEN R, et al: Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants. Eur J Clin Pharmacol 55:645-650, 1999
12. VERROUST PJ, BIRN H, NIELSEN R, et al: The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology. Kidney Int 62:745-756, 2002
13. PATRAKKA J, KESTILA M, WARTIOVAARA J, et al: Congenital nephrotic syndrome (NPHS1): Features resulting from different mutations in Finnish patients. Kidney Int 58:972-980, 2000
14. ANTIKAINEN M, HOLMBERG C, TASKINEN MR: Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis. Clin Nephrol 38:254-263, 1992
15. NG YY, HUANG TP, YANG WC, et al: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54:864-876, 1998
16. YANG SP, WOOLF AS, QUINN F, WINYARD PJ: Deregulation of renal transforming growth factor-betal after experimental short-term ureteric obstruction in fetal sheep. Am J Pathol 159:109-117, 2001
17. IWANO M, PLIETH D, DANOFF TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350, 2002
18. STRUTZ F, OKADA H, LO CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
19. OLDFIELD MD, BACH LA, FORBES JM, et al: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853-1863, 2001
20. LI Y, YANG J, DAI C, et al: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112:503-516, 2003
21. RASTALDI MP, FERRARIO F, GIARDINO L, et al: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62:137-146, 2002
22. JINDE K, NIKOLIC-PATERSON DJ, HUANG XR, et al: Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38:761-769, 2001
23. NADASDY T, LASZIK Z, BLICK KE, et al: Tubular atrophy in the endstage kidney: A lectin and immunohistochemical study. Hum Pathol 25:22-28, 1994
24. YANG J, LIU Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475, 2001
25. FAN JM, NG YY, HILL PA, et al: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467, 1999
26. YANG J, LIU Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13:96-107, 2002
27. WANG Y, RANGAN GK, TAY YC, et al: Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 10:1204-1213, 1999
28. ZOJA C, DONADELLI R, COLLEONI S, et al: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53:1608-1615, 1998
29. FURUICHI K, WADA T, SAKAI N, et al: Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am J Nephrol 20:291-299, 2000
30. OU ZL, NATORI Y, NATORI Y: Gene expression of CC chemokines in experimental acute tubulointerstitial nephritis. J Lab Clin Med 133:41-47, 1999
31. SCHADDE E, KRETZLER M, BANAS B, et al: Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol Dial Transplant 15:1046-1053, 2000
32. TESCH GH, SCHWARTING A, KINOSHITA K, et al: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103:73-80, 1999
33. WADA T, FURUICHI K, SAKAI N, et al: Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58:1492-1499, 2000
34. LAN HY, YANG N, NIKOLIC-PATERSON DJ, et al: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499-509, 2000
35. BRANDT E, LUDWIG A, PETERSEN F, FLAD FLD: Platelet-derived CXC chemokines: Old players in new games. Immunol Rev 177:204-216, 2000
36. EDDY AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135:719-733, 1989
37. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
38. NIKOLIC-PATERSON DJ, HURST L, ATKINS RC: Macrophages in immune renal injury, in Immunologic Renal Disease (2nd ed.), edited by Neilson EG, Couser WG, Philadelphia, Lippincott, Williams & Wilkins, 2001, pp 609-632
39. CHAI Q, KRAG S, CHAI S, et al: Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta 1-induced renal interstitial fibrosis. Histochem Cell Biol 119:267-280, 2003
40. KANG DH, KANELLIS J, HUGO C, et al: Role of the microvascular endothelium in proggressive renal disease. J Am Soc Nephrol 13:806-816, 2002
41. MALLE E, BUCH T, GRONE HJ: Myeloperoxidase in kidney disease. Kidney Int 64:1956-1967, 2003
42. PULLAR JM, WINTERBOURN CC, VISSERS MC: Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid. Am J Physiol 277:1505-1512, 1999
43. ARRIGO AP: Hsp27: Novel regulator of intracellular redox state. IUBMB Life 52:303-307, 2001